Cost-effectiveness of an antiseptic-impregnated central venous catheter in the ICU.
Frank
U
U
Chojnacki
T
T
Dettenkofer
M
M
Daschner
F D
FD
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D016022:Case-Control Studies; D002405:Catheterization, Central Venous / Q000009:adverse effects / Q000191:economics*; D003362:Cost-Benefit Analysis; D005858:Germany; D017048:Health Care Costs; D006801:Humans; D007362:Intensive Care Units; D011446:Prospective Studies; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*; D012837:Silver Sulfadiazine / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D012837:Silver Sulfadiazine